Metoprolol Gemax Pharma (Metoprolol Tartrate)

Metoprolol tartrate selectively antagonises β1‑adrenergic receptors in the heart. By blocking these receptors, it reduces sympathetic stimulation, leading to a slower heart rate, decreased contractile force, and lower cardiac output. The overall effect is reduced blood pressure and diminished oxygen consumption by the heart muscle.

The appropriate dose of Metoprolol Gemax Pharma is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and any comorbidities. Dosage may be adjusted over time, and patients should follow the exact regimen provided by their healthcare professional.

Safety of metoprolol during pregnancy or lactation has not been definitively established. It should only be used when the potential benefit justifies any possible risk to the fetus or infant. Pregnant or nursing patients must discuss the decision with their physician, who will weigh clinical need against safety considerations.

To request Metoprolol Gemax Pharma, visit the product page on gnhindia.com, enter the desired quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Metoprolol tartrate is a cardio‑selective (β1) blocker, offering a lower risk of bronchospasm compared with non‑selective agents such as propranolol. Compared with other selective blockers like atenolol, metoprolol has a shorter half‑life, which may require twice‑daily dosing for stable plasma levels, but provides reliable heart‑rate control in most patients.

Metoprolol Gemax Pharma tablets should be stored at ambient temperature, below 25 °C, in their original packaging to protect from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discoloured.

Metoprolol Gemax Pharma is supplied as oral tablets that are taken by mouth with or without food, as directed by a healthcare professional. Tablets should be swallowed whole with a glass of water; they should not be crushed, chewed, or split unless specifically advised by the prescriber.

Serious risks include severe bradycardia, marked hypotension, heart block, bronchospasm in patients with reactive airway disease, and masking of hypoglycaemia symptoms in diabetic individuals. Patients should seek immediate medical attention if they experience fainting, extreme fatigue, difficulty breathing, or signs of allergic reaction.

Metoprolol Gemax Pharma is contraindicated in patients with known hypersensitivity to metoprolol or any component of the formulation, those with severe bradycardia, second‑ or third‑degree heart block without a pacemaker, and individuals with uncompensated heart failure or cardiogenic shock. Consultation with a physician is essential before starting therapy.